Leading Scientists Join Together to Prepare for the Next Global Pandemic CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Oct. 20, 2020 /PRNewswire/ — Celdara Medical announced today the launch of the Pandemic Security Initiative’s Scientific Advisory Board (SAB), a group of outstanding scientists and infectious disease experts. The SAB is an integral part of […]
Celdara Medical, LLC today announced that DRIVEN Accelerator Hub Participant Company, CoreMap, has closed a Series A investment of $10.5 M led by Qure Ventures. The round included existing investors such as Ronny Ginor, MD of Fifth Focus/HRMG Investments and Orbimed Venture Partners, and a diverse group of new strategic, corporate, and financial partners. Of the eight companies that have participated in the NIH-funded DRIVEN Accelerator […]
CAMBRIDGE, MA. and LEBANON, NH. and NEW YORK, NY. Aug. 12, 2020 /PRNewswire/ — Celdara Medical (“Celdara”) announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Small Business Innovation Research (SBIR) grant to fund the company’s development of […]
Celdara Medical today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.
Celdara Medical, a clinical-stage biotechnology company focused on delivering products to patients, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and The Geneva Foundation, 501(c)3 non-profit organization that advances military medical research.
Celdara Medical announces the publication of new translational research in the American Journal of Transplantation indicating that a novel polymer therapeutic candidate, APP-103TM, is able to preserve kidney function in preclinical models of kidney ischemia reperfusion injury, including transplantation.
Celdara Medical, LLC today announced that the first DRIVEN Accelerator Hub Participant Company, CairnSurgical, Inc., has closed a Series A investment led by Morningside Group.
Celdara Medical, LLC and Simbex today announced the award of $250,000 in supplemental funds to the DRIVEN Accelerator Hub. The DRIVEN Accelerator Hub is an NIH-funded consortium led by Celdara Medical (therapeutics and diagnostics) and Simbex (medical devices and digital health) and includes 10 of the leading research institutions in the Northeast. The supplemental funds will be used to create the following programs:
Celdara Medical, LLC today announced the launch of an online resource database for biomedical entrepreneurs: bioentrepreneurresources.com. This database was developed by the DRIVEN Accelerator Hub, an NIH-funded consortium led by Celdara Medical including 10 of the leading research institutions in the Northeast region (NH, VT, ME, DE, and RI). The database is open to biomedical entrepreneurs globally and contains resources from across the country. New resources are added by user submission and curated by DRIVEN.